The impact of bifurcation angle on clinical outcomes in patients who underwent nano-crush technique: the insight from the multicenter EVOLUTE-CRUSH V study
Ahmet Yaşar Çizgici, Ahmet Güner, Elnur Alizade, İlyas Çetin, Ebru Serin, Abdullah Doğan, Kaan Gökçe, Berkay Serter, Koray Çiloğlu, İbrahim Faruk Aktürk, Hande Uysal, Ezgi Gültekin Güner, Cemalettin Akman, Aybüke Şimşek, Fatih Furkan Bedir, Veysel Ozan Tanik, Kudret Keskin, Hamdi Püşüroğlu, Merve Aydin, Emre Aydin, Büşra Çörekçioğlu, Mehmet Köseoğlu, Fatih UzunBackground
This multicenter study aimed to retrospectively assess the relationship between bifurcation angle (BA) and major cardiovascular events (MACEs) in patients undergoing nano-crush technique (NCT) for complex bifurcation lesions (CBLs).
Methods
A total of 122 consecutive patients [male: 85 (69.6%), mean age: 61.53 ± 9.03 years] who underwent NCT between January 2019 and January 2024 were included. The primary endpoint was a combined endpoint (MACE) including cardiac death, target vessel myocardial infarction (TVMI), or clinically driven target lesion revascularization (TLR). Patients were classified into two groups: MACE-positive and MACE-negative patients.
Results
Among the study population, 22 patients (18%) had at least one MACE. The BA (46.89 ± 14.65° vs. 65.23 ± 10.40°,
Conclusion
This observational multicenter study showed that the BA significantly affects mid-term outcomes in patients who underwent NCT. In addition, our findings suggest that NCT may not be a viable option in patients with narrow-angle (<70°) CBLs.